發(fā)布時(shí)間：2018-11-05 09:35

【摘要】： 目的:糖皮質(zhì)激素廣泛應(yīng)用于臨床疾病的治療。長(zhǎng)期全身、局部應(yīng)用糖皮質(zhì)激素可導(dǎo)致激素性白內(nèi)障,其發(fā)病機(jī)制尚不明確。目前已證實(shí)晶狀體上皮細(xì)胞存在糖皮質(zhì)激素受體。糖皮質(zhì)激素作用于人晶狀體上皮細(xì)胞后,與其受體結(jié)合,其激素受體復(fù)合物與相應(yīng)靶基因的糖皮質(zhì)激素反應(yīng)元件(GRE)結(jié)合后調(diào)控大量靶基因的轉(zhuǎn)錄,進(jìn)而影響相應(yīng)靶基因的功能。其中主要涉及細(xì)胞膜的轉(zhuǎn)運(yùn)和細(xì)胞骨架結(jié)構(gòu)的改變等。晶狀體通過Na+,K+-ATP酶維持離子進(jìn)出細(xì)胞的平衡,其功能的改變將會(huì)引起晶狀體細(xì)胞內(nèi)水鈉潴留,形成白內(nèi)障。波形蛋白是重要的細(xì)胞骨架蛋白,在晶狀體上皮細(xì)胞中適量表達(dá),對(duì)于維持晶狀體細(xì)胞正常的形態(tài)和功能,具有重要意義。本實(shí)驗(yàn)將應(yīng)用糖皮質(zhì)激素受體拮抗劑RU486探討糖皮質(zhì)激素受體介導(dǎo)的大鼠激素性白內(nèi)障Na+,K+-ATP酶和波形蛋白的變化,探討糖皮質(zhì)激素受體在激素性白內(nèi)障的發(fā)病中的作用機(jī)制。 方法:大鼠透明晶狀體隨機(jī)分為對(duì)照組、糖皮質(zhì)激素誘導(dǎo)的激素白內(nèi)障組(地塞米松5μM)、糖皮質(zhì)激素受體拮抗劑RU486組(地塞米松5μM+RU486 5μM)。離體晶狀體孵育7天,倒置顯微鏡動(dòng)態(tài)觀察晶狀體的透明度。HE染色分析三組晶狀體的組織形態(tài)學(xué)變化,分光光度計(jì)動(dòng)態(tài)分析Na+,K+-ATP酶的活性,蛋白質(zhì)印跡法和免疫組化法分析Na+,K+-ATP酶α1和波形蛋白的蛋白表達(dá),RT-PCR分析Na+,K+-ATP酶α1和波形蛋白的mRNA表達(dá)。 結(jié)果:白內(nèi)障組與其它兩組相比,晶狀體在第5天出現(xiàn)霧狀混濁(P0.05),第7天霧狀混濁更明顯(P0.01),而對(duì)照組和拮抗劑組保持透明。白內(nèi)障組與其它兩組相比,Na+,K+-ATP酶活性隨孵育時(shí)間的延長(zhǎng)而逐漸下降(P0.001),而對(duì)照組和拮抗劑組無(wú)明顯變化。HE染色顯示白內(nèi)障組與對(duì)照組和拮抗劑組相比,晶狀體纖維結(jié)構(gòu)排列紊亂,細(xì)胞間隙增寬。白內(nèi)障組Na+,K+-ATP酶α1蛋白和mRNA表達(dá)下降,而對(duì)照組和拮抗劑組表達(dá)正常。白內(nèi)障組波形蛋白的蛋白表達(dá)下降,而對(duì)照組和拮抗劑組表達(dá)正常。三組中波形蛋白mRNA表達(dá)無(wú)明顯改變。 結(jié)論:本研究表明糖皮質(zhì)激素受體介導(dǎo)的晶狀體Na+,K+-ATP酶α1和酶活性以及波形蛋白的改變參與了激素性白內(nèi)障的形成,并且發(fā)揮著重要作用。
[Abstract]:Objective: glucocorticoids are widely used in the treatment of clinical diseases. Long-term systemic, local use of glucocorticoid can lead to hormone-induced cataract, its pathogenesis is unclear. The presence of glucocorticoid receptors in lens epithelial cells has been confirmed. Glucocorticoid acts on human lens epithelial cells and binds to its receptor. The hormone receptor complex binds to the glucocorticoid response element (GRE) of the corresponding target gene and regulates the transcription of a large number of target genes. Furthermore, the function of the target gene is affected. It mainly involves cell membrane transport and cytoskeleton structure change. Lens maintains the balance of ion entering and leaving cells through Na, K-ATP enzyme, and the change of its function will lead to the retention of water and sodium in lens cells and the formation of cataract. Vimentin is an important cytoskeleton protein which is expressed in lens epithelial cells and plays an important role in maintaining the normal morphology and function of lens cells. In this study, glucocorticoid receptor antagonist (RU486) was used to investigate the changes of Na, K-ATP enzyme and vimentin in glucocorticoid receptor-mediated rat steroid-induced cataract. To explore the role of glucocorticoid receptor in the pathogenesis of hormonal cataract. Methods: rat clear lens were randomly divided into control group and glucocorticoid-induced cataract group (dexamethasone 5 渭 M), glucocorticoid receptor antagonist RU486 group (dexamethasone 5 渭 M RU486 5 渭 M). After incubation for 7 days in vitro, the transparency of the lens was observed dynamically by inverted microscope. The histomorphological changes of the three groups were analyzed by HE staining and the activity of Na, K-ATP enzyme was dynamically analyzed by spectrophotometer. Protein expression of Na, K-ATP enzyme 偽 1 and vimentin was detected by Western blot and immunohistochemistry, and mRNA expression of Na, K ATP enzyme 偽 1 and vimentin by RT-PCR. Results: compared with the other two groups, the lens haze appeared on the 5th day (P0.05), and on the 7th day it was more obvious (P0.01), while the control group and the antagonist group remained transparent. Compared with the other two groups, the activity of, Na, K-ATP enzyme in cataract group decreased gradually with the increase of incubation time (P0. 001), but there was no significant change in control group and antagonist group. HE staining showed that the activity of, Na, K-ATP enzyme in cataract group was higher than that in control group and antagonist group. The structure of lens fibers was disordered and the intercellular space widened. The expression of Na, K-ATP 偽 1 protein and mRNA decreased in cataract group, but normal in control group and antagonist group. The expression of vimentin decreased in cataract group, but normal in control group and antagonist group. There was no significant change in vimentin mRNA expression in the three groups. Conclusion: this study suggests that glucocorticoid receptor mediated changes in Na, K-ATP 偽 1, enzyme activity and vimentin play an important role in the formation of hormonal cataract.
【學(xué)位授予單位】：第四軍醫(yī)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2010
【分類號(hào)】：R776.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前6條

1 王建偉,嚴(yán)宏,王永強(qiáng),哈文靜,丁正華,郭勇;地塞米松誘導(dǎo)大鼠白內(nèi)障形態(tài)學(xué)及酶活性變化[J];第四軍醫(yī)大學(xué)學(xué)報(bào);2005年21期

2 王建偉,嚴(yán)宏,劉兵,哈文靜,王永強(qiáng),丁正華;大鼠激素性白內(nèi)障中Na~+-K~+ATP酶活性的變化[J];國(guó)際眼科雜志;2005年05期

3 嚴(yán)宏,劉兵,俞蘭,王為農(nóng);糖皮質(zhì)激素對(duì)α-晶狀體蛋白分子伴侶功能的影響[J];眼科研究;2005年01期

4 周健,惠延年,李燕,林英華,張平,蔡翔;波形纖維蛋白在老年性白內(nèi)障晶狀體上皮細(xì)胞的表達(dá)[J];中華眼科雜志;2001年05期

5 葉天才，，劉東光，余敏斌，孫桂珍;糖皮質(zhì)激素性白內(nèi)障93例臨床分析[J];中華眼科雜志;1995年06期

6 徐國(guó)興,王婷婷;波形蛋白在老年性白內(nèi)障晶狀體上皮細(xì)胞中的表達(dá)及其意義[J];眼視光學(xué)雜志;2002年04期

本文編號(hào)：2311661